C
CSPC Pharmaceutical Group Ltd
HKEX:1093
CSPC Pharmaceutical Group Ltd
HKEX:1093
Price:
8.86
HKD
12.72%
Market Cap:
102.3B
HKD
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
12.7
Current
7.5
Median
12.8
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=12.7
Enterprise Value
/
93.3B HKD
EBITDA
6.7B CNY
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
10.4
2-Years Forward
EV/EBITDA
10.6
3-Years Forward
EV/EBITDA
10.2
You don't have any saved screeners yet
